Commentary on "Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer" by Shaker A. Mousa, Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, United States - Peptide-Conjugated Nanoparticles for Multimodal Nanomedicine
- PMID: 32515306
- DOI: 10.2174/092986732717200604120627
Commentary on "Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer" by Shaker A. Mousa, Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, United States - Peptide-Conjugated Nanoparticles for Multimodal Nanomedicine
Comment on
-
Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer.Curr Med Chem. 2019;26(30):5664-5683. doi: 10.2174/0929867326666190620100800. Curr Med Chem. 2019. PMID: 31250748 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical